Schrödinger will be attending Frontiers in Medicinal Chemistry from March 17th-20th in Munich, Germany. Senior Applications Scientist Daniel Cappel will be presenting the poster "Impact of binding site waters on inhibitor design: contemplating a novel inverse binding mode of indirubin derivatives in DYRK kinases."